Abstract
We offered an advanced nanohybrid formulation system of Sulindac (SUL) based on layered double hydroxide (LDH) nanoparticles. The formulated materials were characterized by X-rays, Infrared and SEM techniques to confirm the nanohybrid structure. The drug incorporation ratio was determined to be 45%. The drug solubility was improved after the LDH nanohybrid formation. The anion-exchange mechanism of LDH supported the dissolution process for the intercalated SUL.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Modern Physics: Conference Series
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
